Company Summary

GenomeRx is an early stage clinical diagnostic company focused on improving the lives of cancer patients by early diagnosis of cancer, predicting patients with more likelihood of acquiring cancer, and likelihood of recurrence and response to chemo- or radiotherapy for cancer patients after surgery. The primary focus of GenomeRx is to help Head and Neck Squamous Cell Carcinoma (HNSCC) patients. We plan to launch the product in the 3rd year.

Team

Narendra Vaish, PhD, MBA

President and CSO

Dr. Vaish brings more than 15 years of drug discovery and diagnostic experience. He was instrumental in establishing founding allosteric ribozyme technologies for nucleic acids and protein detection at Ribozyme Pharmaceuticals. He also developed founding siRNA drug discovery platforms at Sirna Therapeutics and at Marina Biotech. Dr. Vaish has >150 patents or patent applications pending on various genes, diagnostic and therapeutic technologies.

Dr. Agarwal is a highly qualified pathologist who brings in many years of translational research and pathology experience in the fields of HNSCC, breast cancer and lymphomas. Dr. Agarwal has extensive experience in both neoplastic and non-neoplastic pathology in the eastern and western world and also well versed with animal histopathology.